Detail Information of Exogenous Modulation
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0245 Transporter Info | ||||
Gene Name | SLC28A2 | ||||
Transporter Name | Concentrative nucleoside transporter 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM) | |||||
---|---|---|---|---|---|
Approved Drug |
|||||
Trichostatin A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Trichostatin A inhibits histone deacetylase, which then enhances Cladribine's transportation via increasing the histone acethylation level of SLC28A2 | [1] | |||
Affected Drug/Substrate |
Cladribine | Modulation Type | Inducer | ||
Cell System |
CRC cell lines HCT15 and HT29 | ||||
Floxuridine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Floxuridine inhibits the transportation of Inosine by SLC28A2 | [2] | |||
Affected Drug/Substrate |
Inosine | Modulation Type | Inhibition | ||
Cell System |
Monkey kidney tissue Fibroblast-like cell lines (COS)7-CNT2 | ||||
Adenosine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Adenosine inhibits the transportation of Uridine by SLC28A2 | [3] | |||
Affected Drug/Substrate |
Uridine | Modulation Type | Inhibition | ||
Carbamazepine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Carbamazepine affects the expression of SLC28A2 | [4] | |||
Valproic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Valproic Acid increases the expression of SLC28A2 | [5] | |||
Acetaminophen |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Acetaminophen increases the expression of SLC28A2 | [6] | |||
Uridine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Uridine inhibits the activity of SLC28A2 | [3] | |||
Drug in Preclinical Test |
|||||
(+)-JQ1 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
(+)-JQ1 inhibits the expression of SLC28A2 | [7] | |||
Discontinued Drug |
|||||
Tecadenoson |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Tecadenoson inhibits the transportation of Uridine by SLC28A2 | [3] | |||
Affected Drug/Substrate |
Uridine | Modulation Type | Inhibition | ||
Investigative Drug |
|||||
Phlorizin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Phlorizin inhibits the transportation of Inosine by SLC28A2 | [2] | |||
Affected Drug/Substrate |
Inosine | Modulation Type | Inhibition | ||
Cell System |
Monkey kidney tissue Fibroblast-like cell lines (COS)7-CNT2 | ||||
Carcinogen |
|||||
Benzo(a)pyrene |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Benzo(a)pyrene inhibits the expression of SLC28A2 | [8] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.